Evidence map›Paper›PMID 40234550›Full record

ArticleScientific reports2025

High tissue specificity of lncRNAs maximises the prediction of tissue of origin of circulating DNA.

Elyas Mouhou, Fabien Genty, Walid El M'selmi, Hanae Chouali, Jean-François Zagury, Sigrid Le Clerc, Charlotte Proudhon, Josselin Noirel

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Current issues in molecular biology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elyas MouhouLaboratoire GBCM (EA7528), Conservatoire national des arts et métiers (CNAM), Paris, France.
Fabien Genty *Infotel Conseil, 13, rue Madeleine-Michelis, Neuilly-sur-Seine, France.
Walid El M'selmi *Adobe Systems France, 94, rue Lauriston, Paris, France.
Hanae ChoualiBioinfOmics, GenoToul Bioinformatics facility, Université Fédérale de Toulouse, INRAE, Castanet-Tolosan, France.
Jean-François ZaguryLaboratoire GBCM (EA7528), Conservatoire national des arts et métiers (CNAM), Paris, France.
Sigrid Le ClercLaboratoire GBCM (EA7528), Conservatoire national des arts et métiers (CNAM), Paris, France.
Charlotte ProudhonUniversité de Rennes, Inserm, EHESP, Irset, Rennes, France.
Josselin NoirelLaboratoire GBCM (EA7528), Conservatoire national des arts et métiers (CNAM), Paris, France. josselin.noirel@cnam.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have made it possible to envision a translational application of plasma DNA sequencing in cancer diagnosis and monitoring. However, the extremely low concentration of circulating tumour DNA (ctDNA) fragments among the total cell-free DNA (cfDNA) remains a formidable challenge to overcome and statistical models have yet to be improved enough to become of practical use. In this study, we set about appraising the predictive value of a variety of binary classification models based on cfDNA sequencing using fragmentation features extracted around transcription start sites (TSSs). We investigated (1) features summarising mapped fragment density around each TSS, (2) long non-coding RNA (lncRNA) genes versus coding genes and (3) selection criteria to generate gene classes to be assigned by the model. Given that, in healthy samples, most of the cfDNA comes from lymphomyeloid lineages, we could identify the model parametrisation with the best accuracy in those lineages using publicly available datasets of healthy patients' cfDNA. Our results show that (1) the way tissue-specific gene classes are defined matters more than what fragmentation features are included, and (2) in particular, lncRNAs are more tissue specific than coding genes and stand out in terms of both sensitivity and specificity in our results.

Indexed as

Cell-Free Nucleic AcidsCirculating Tumor DNANeoplasmsRNA, Long NoncodingBiomarkers, TumorHumansOrgan SpecificityTranscription Initiation SiteBiomarkers, TumorCell-Free Nucleic AcidsCirculating Tumor DNARNA, Long Noncoding

Identifiers

PMID40234550
PMCPMC12000428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.